Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease.
Saved in:
| Title: | Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease. |
|---|---|
| Authors: | Singer D; GSK, Philadelphia, PA, USA. Electronic address: david.a.singer@gsk.com., La EM; GSK, Philadelphia, PA, USA., Dubois de Gennes C; GSK, London, United Kingdom., Graham J; RTI Health Solutions, LLC, Research Triangle Park, NC, USA., Grace M; RTI Health Solutions, LLC, Research Triangle Park, NC, USA., Biundo E; GSK, Wavre, Belgium., Verelst F; GSK, Wavre, Belgium. |
| Source: | Vaccine [Vaccine] 2026 Jun 25; Vol. 88, pp. 128770. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42349134 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Singer+D%22">Singer D</searchLink>; GSK, Philadelphia, PA, USA. Electronic address: david.a.singer@gsk.com.<br /><searchLink fieldCode="AU" term="%22La+EM%22">La EM</searchLink>; GSK, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dubois+de+Gennes+C%22">Dubois de Gennes C</searchLink>; GSK, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Graham+J%22">Graham J</searchLink>; RTI Health Solutions, LLC, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Grace+M%22">Grace M</searchLink>; RTI Health Solutions, LLC, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Biundo+E%22">Biundo E</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Verelst+F%22">Verelst F</searchLink>; GSK, Wavre, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Jun 25; Vol. 88, pp. 128770. <i>Date of Electronic Publication: </i>2026 Jun 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42349134 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2026.128770 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 128770 Titles: – TitleFull: Public health impact and cost-effectiveness of adjuvanted RSVPreF3 vaccination among US adults aged 18-49 years at increased risk for severe RSV disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Singer D – PersonEntity: Name: NameFull: La EM – PersonEntity: Name: NameFull: Dubois de Gennes C – PersonEntity: Name: NameFull: Graham J – PersonEntity: Name: NameFull: Grace M – PersonEntity: Name: NameFull: Biundo E – PersonEntity: Name: NameFull: Verelst F IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 06 Text: 2026 Jun 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 88 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
